Foot and Mouth Disease News and Research

RSS
Fatal outcome from HFMD is rare, says LUHS pediatric infectious disease specialist

Fatal outcome from HFMD is rare, says LUHS pediatric infectious disease specialist

Enterovirus blamed for some deaths of Cambodian children; Officials continue to investigate mysterious respiratory illness

Enterovirus blamed for some deaths of Cambodian children; Officials continue to investigate mysterious respiratory illness

Sinovac provides update on EV71 vaccine Phase III trial on HFMD

Sinovac provides update on EV71 vaccine Phase III trial on HFMD

Sinovac first quarter sales increase 30.3% to $6.0M

Sinovac first quarter sales increase 30.3% to $6.0M

GenVec 2011 net loss decreases to $7.4 million

GenVec 2011 net loss decreases to $7.4 million

Top-line results from Inviragen's INV21 Phase 1 trial on HFMD

Top-line results from Inviragen's INV21 Phase 1 trial on HFMD

Critical new details about structure of enterovirus 71

Critical new details about structure of enterovirus 71

Good surveillance system for FMD can minimize economic losses to Mexican cattle industry

Good surveillance system for FMD can minimize economic losses to Mexican cattle industry

Inviragen presents DENVax Phase 1 trial results on dengue at ASTMH annual meeting

Inviragen presents DENVax Phase 1 trial results on dengue at ASTMH annual meeting

Sinovac third quarter sales increase 60.8% to $15.4 million

Sinovac third quarter sales increase 60.8% to $15.4 million

Vietnam closes kindergartens to control outbreak of hand, foot and mouth disease

Vietnam closes kindergartens to control outbreak of hand, foot and mouth disease

Researchers investigate potential of vesicular stomatitis virus against soft tissue sarcomas

Researchers investigate potential of vesicular stomatitis virus against soft tissue sarcomas

Outbreak of hand, foot and mouth disease kills 81 children in Vietnam

Outbreak of hand, foot and mouth disease kills 81 children in Vietnam

Sinovac second quarter sales increase 52.5% to $15.7 million

Sinovac second quarter sales increase 52.5% to $15.7 million

Preventing bioterrorism worldwide

Preventing bioterrorism worldwide

Vaccines may be given in food in the near future

Vaccines may be given in food in the near future

Inviragen commences INV21 Phase 1 trial against Hand, Foot and Mouth Disease

Inviragen commences INV21 Phase 1 trial against Hand, Foot and Mouth Disease

Merial, GenVec extend deal to develop and commercialize foot-and-mouth disease vaccine

Merial, GenVec extend deal to develop and commercialize foot-and-mouth disease vaccine

Sinovac reports fourth quarter net sales of $9.1 million

Sinovac reports fourth quarter net sales of $9.1 million

U.S., S. Korea in talks over how to respond to food aid request by N. Korea

U.S., S. Korea in talks over how to respond to food aid request by N. Korea